Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST: FOLFOX6, SIR-Spheres, and Bevacizumab in Colorectal Liver Metastases
NCT00735241Phase 3Withdrawn
- Sponsor
- Sirtex
- Start
- Jul 2008
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal carcinoma (CRC), sponsored by Sirtex. Planned start Jul 2008; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT00735241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735241.